Recommendations for Prevention and control of infections in neonatal intensive care unit patients: Staphylococcus aureus

It provides new, evidence-based recommendations specific to the prevention and control of S. aureus, including MRSA and MSSA, in neonatal intensive care unit (NICU) patients. It does not provide a comprehensive set of infection control recommendations for the prevention of S. aureus in NICU patients, but instead supplements other CDC guidelines. Based on a systematic review focusing key questions:

  1. What are effective strategies for preventing S. aureus transmission from colonized or infected NICU patients to other patients, and do these strategies differ between MRSA and MSSA or in the setting of an outbreak?
  2. If screening is conducted, which anatomic sampling sites and laboratory assays most effectively identify S. aureus colonization in NICU patients?
  3. What are the risk factors and risk indicators for S. aureus infection in NICU patients, and do these factors differ between MRSA and MSSA or in the setting of an outbreak?
  4. What are the risk factors and risk indicators for S. aureus colonization in NICU patients, and do these factors differ between MRSA and MSSA or in the setting of an outbreak?

https://www.cdc.gov/infectioncontrol/guidelines/NICU-saureus